Article thumbnail

Carotid plaque regression following 6-month statin therapy assessed by 3T cardiovascular magnetic resonance: comparison with ultrasound intima media thickness

By Raymond Q Migrino, Mark Bowers, Leanne Harmann, Robert Prost and John F LaDisa
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3166901
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2008). 5 Tesla: impact on automatic classification.
  2. (1993). A multicenter comparative trial of lovastatin and pravastatin in the treatment of hypercholesterolemia.
  3. (2001). Badimon JJ: Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation
  4. (2007). Bots ML: Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis. JAMA
  5. C: Signal features of the atherosclerotic plaque at 3.0 Tesla versus
  6. (1999). Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults.
  7. (2007). Comparative performance of subclinical atherosclerosis tests in predicting coronary heart disease in asymptomatic individuals. Eur Heart J
  8. (2007). Disease and Stroke Statistics -
  9. (2005). E: Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial.
  10. (2001). EA: Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model. J Vasc Surg
  11. (2009). et al: Cross-sectional, prospective study of MRI reproducibility in the assessment of plaque burden of the carotid arteries and aorta. Nature Clinical Practice
  12. (2008). et al: Early changes in arterial structure and function following statin initiation: quantification by magnetic resonance imaging. Atherosclerosis
  13. (1994). et al: Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation
  14. (2003). et al: Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA
  15. (2005). et al: Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging.
  16. (1996). et al: Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study.
  17. (2008). et al: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
  18. (2005). et al: Sample size calculation for clinical trials using magnetic resonance imaging for the quantitative assessment of carotid atherosclerosis.
  19. (2001). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA
  20. (2009). Extended-release niacin or ezetimibe and carotid intima-media thickness.
  21. (2005). Gilst WH: Effects of fosinopril and pravastatin on carotid intimamedia thickness in subjects with increased albuminuria. Stroke
  22. (2001). Hatsukami TS: In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation
  23. (1998). Hatsukami TS: Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation
  24. (2004). Huisman MV: Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease. Diabetes Care
  25. (2005). Long-term safety and efficacy of high-dose atorvastatin treatment in patients with familial hypercholesterolemia.
  26. (2009). Magnetic resonance imaging and three-dimensional ultrasound of carotid atherosclerosis: mapping regional differences.
  27. (2009). Michos ED: The HALTS trial–halting atherosclerosis or halted too early?
  28. (2010). Migrino RQ: Time-efficient patient-specific quantification of regional carotid artery fluid dynamics and spatial correlation with plaque burden following statin treatment. Med Phys
  29. (2006). Multicontrast black-blood MRI of carotid arteries: comparison between 1.5 and 3 tesla magnetic field strengths.
  30. (2009). Neurovascular imaging at 1.5 tesla versus 3.0 tesla.
  31. (1998). Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.
  32. (2002). Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebocontrolled trial. Lancet
  33. (1994). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet
  34. (2003). Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin.
  35. (2005). Rutt BK: Variation in the carotid bifurcation geometry of young versus older adults: implications for geometric risk of atherosclerosis. Stroke
  36. (2004). S: Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Circulation
  37. (2008). Scanrescan and intra-observer variability of magnetic resonance imaging of carotid atherosclerosis at 1.5 T and 3.0 T. Phys Med Biol
  38. (2001). Stalenhoef AF: Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. Lancet
  39. (2001). T: Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA
  40. (2002). Vernalis MN: ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation